Please login to the form below

Not currently logged in
Email:
Password:

Ogilvy PR adds to senior health team

Three of the New York office’s six new hires have been recruited to the healthcare team

Ogilvy PR Kara GolubOgilvy Public Relations has announced several senior hires, including three to its healthcare practice.

Kara Golub, Linda Ruckel and Christopher Wahlers – all vice presidents – have already stepped into their new roles at the integrated communications firm.

Golub (pictured top right) joined Ogilvy from Ruder Finn, where she implemented high-profile consumer campaigns, data and regulatory announcements, and social media initiatives. In her new role, she will provide strategic communications counsel for a range of clients, including Boehringer Ingelheim.

Ogilvy PR Linda RuckelRuckel (pictured left) has been recruited to support the Agency for Healthcare Research and Quality on partnership development and dissemination of treatment options information. She was previously vice president in MSLGroup's health and medical centre practice.

Wahlers (pictured bottom right) specialises in developing strategic planning and programming. He left MWW Group for Ogilvy – also a vice president with the former, he created and managed campaigns for Deloitte Life Services Health Care.

Ogilvy PR Chris Wahlers

The recruitment spree was prompted by 'incremental growth, involving both new and existing clients, in the healthcare group', an Ogilvy spokesperson told PMLiVE. The agency is still hiring, and has several openings, she said.

1st October 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics